Skip to main content

3 Result(s)

within Sumithra J. Mandrekar Remove this filter Hematology Remove this filter Intensive / Critical Care Medicine Remove this filter

and

  1. No Access

    Article

    Clinical evaluation of complete remission (CR) with partial hematologic recovery (CRh) in acute myeloid leukemia: a report of 7235 patients from seven cohorts

    Jacob S. Appelbaum, Andrew H. Wei, Sumithra J. Mandrekar, Ing S. Tiong… in Leukemia (2024)

  2. No Access

    Article

    Adverse event burden in older patients with CLL receiving bendamustine plus rituximab or ibrutinib regimens: Alliance A041202

    Ibrutinib has superior progression-free survival compared with bendamustine plus rituximab (BR) in older CLL patients, however, differences in treatment duration, six monthly BR cycles versus continuous ibruti...

    Amy S. Ruppert, Allison M. Booth, Wei Ding, Nancy L. Bartlett… in Leukemia (2021)

  3. No Access

    Article

    Midostaurin reduces relapse in FLT3-mutant acute myeloid leukemia: the Alliance CALGB 10603/RATIFY trial

    The prospective randomized, placebo-controlled CALGB 10603/RATIFY trial (Alliance) demonstrated a statistically significant overall survival benefit from the addition of midostaurin to standard frontline chemo...

    Richard A. Larson, Sumithra J. Mandrekar, Lucas J. Huebner, Ben L. Sanford… in Leukemia (2021)